NVS Novartis AG

91.301.54 (+1.72%)
Close: June 18, 2019

Quote

Previous Close
$91.30
Day Range
$90.98-$91.63
52 Week Range
$72.30-$96.31
Volume
2,258,416
Avg Volume
1,995,314
Dividend TTM
$1.84 (2.05%)
Ex-Dividend Date
0000-00-00

Valuation

Market Cap
-
Enterprise Value (EV)
$221.50B
PE Ratio
17.18
EV/EBITDA
14.63
Price/Sales
3.95
Price/Book
2.66
PEG Ratio
2.48

Financials

Revenue
$52.02B
Gross Profit
$33.57B
EBITDA
$15.14B
EPS, ttm
$5.31
Profit Margin
24.30%
Revenue/Employee
$415.61K
Next Earnings Date
7/18/2019 (29 days)
Debt to Equity
41%
Debt
$237.45B
Cash
$15.95B
Net Debt
$221.50B

Performance

Beta
0.57
200 Day Moving Avg
$86.79
50 Day Moving Avg
$83.69
52 Week Change
21.15%
YTD Change
8.50%
1 Month Change
9.45%
3 Month Change
-3.66%
6 Month Change
5.12%
1 Year Change
21.15%
2 Year Change
6.25%
5 Year Change
-6.27%

Share Count

Shares Outstanding
-

Novartis AG Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Vasant Narasimhan

Website: http://www.novartis.com

Description: Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following four segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Employees: 125,161